Short Professional summary

His research focuses on evidence-based myopia management, including atropine dose–response, combination therapies and growth-curve interpretation. He co-leads clinical and epidemiological studies such as the MAD trial on atropine dosing in European children, and contributes to cohorts (e.g., Generation R) on ocular development and risk factors. Polling advises on guideline development and public health strategies, lectures internationally, and collaborates with clinicians and partners to translate research into pragmatic care pathways that slow progression and reduce complications.